UY24698A1 - Promotor regulado por hierro y usos del mismo - Google Patents
Promotor regulado por hierro y usos del mismoInfo
- Publication number
- UY24698A1 UY24698A1 UY24698A UY24698A UY24698A1 UY 24698 A1 UY24698 A1 UY 24698A1 UY 24698 A UY24698 A UY 24698A UY 24698 A UY24698 A UY 24698A UY 24698 A1 UY24698 A1 UY 24698A1
- Authority
- UY
- Uruguay
- Prior art keywords
- iron
- sequence
- promoter
- promoter regulated
- regulated
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Invento que proporciona un promotor regulado por hierro y su uso para la expresión de polipéptidos y en particular su uso en vacunas vivas, el cual comprende una secuencia de ADN que incluye la secuencia de los residuos 284 a 409 (figura 1), o una secuencia de ácido nucleico funcionalmente equivalente. También se proporcionan vectores y células huéspedes recombinantes incluyendo el promotor y composiciones utilizadas para inducir una respuesta inmunitaria en un animal.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO2164A AUPO216496A0 (en) | 1996-09-06 | 1996-09-06 | Inducible promoters |
AUPO2454A AUPO245496A0 (en) | 1996-09-19 | 1996-09-19 | Site-specific chromosomal integration system |
AUPO7801A AUPO780197A0 (en) | 1997-07-09 | 1997-07-09 | Site-specific chromosomal integration system incorporating inducible promoter |
Publications (1)
Publication Number | Publication Date |
---|---|
UY24698A1 true UY24698A1 (es) | 1998-02-12 |
Family
ID=27157946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY24698A UY24698A1 (es) | 1996-09-06 | 1997-09-05 | Promotor regulado por hierro y usos del mismo |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0964924A4 (es) |
AR (1) | AR008171A1 (es) |
BR (1) | BR9711692A (es) |
CA (1) | CA2265883A1 (es) |
NZ (1) | NZ334649A (es) |
UY (1) | UY24698A1 (es) |
WO (1) | WO1998010064A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2097931C (en) * | 1990-12-18 | 2003-07-29 | Samuel I. Miller, Iii | Salmonella vaccines |
AU683454B2 (en) * | 1993-02-22 | 1997-11-13 | General Hospital Corporation, The | Heterologous antigens in live cell vaccine strains |
-
1997
- 1997-08-08 CA CA002265883A patent/CA2265883A1/en not_active Abandoned
- 1997-08-08 NZ NZ334649A patent/NZ334649A/xx unknown
- 1997-08-08 EP EP97933590A patent/EP0964924A4/en not_active Withdrawn
- 1997-08-08 BR BR9711692-0A patent/BR9711692A/pt unknown
- 1997-08-08 WO PCT/AU1997/000503 patent/WO1998010064A1/en not_active Application Discontinuation
- 1997-09-05 UY UY24698A patent/UY24698A1/es not_active Application Discontinuation
- 1997-09-08 AR ARP970104095A patent/AR008171A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0964924A4 (en) | 2001-04-18 |
NZ334649A (en) | 2000-08-25 |
EP0964924A1 (en) | 1999-12-22 |
AR008171A1 (es) | 1999-12-09 |
WO1998010064A1 (en) | 1998-03-12 |
BR9711692A (pt) | 2000-10-24 |
CA2265883A1 (en) | 1998-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR247590A1 (es) | Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion | |
ES2070866T3 (es) | Vacunas recombinantes contra la coccidiosis. | |
CY1105364T1 (el) | Μεθοδοι και συνθεσεις διαμορφωσης ανοσοποιησης | |
PH25747A (en) | Recombinant vaccinia vrus mva | |
ATE444360T1 (de) | T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe) | |
BR9605153B1 (pt) | vacina de combinação, e, kit de vacinação. | |
DZ634A1 (fr) | Mutants de vibrio cholerale non-toxinogènes. | |
DK216289D0 (da) | Rekombinant - dna - afledte bordetella-toxinunderenheder og analoge deraf | |
MX9204685A (es) | Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina. | |
ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
ES2103928T3 (es) | Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis. | |
DK251890D0 (da) | Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering | |
ATE347599T1 (de) | Tuberkulose impfstoff | |
IT1262895B (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
DK0588578T3 (da) | Immunogener | |
NL980006I1 (nl) | Antigeen-preparaten en isolering van dergelijke preparaten. | |
NO20002504L (no) | Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener | |
DK0425082T3 (da) | Vacciner | |
DK1147212T3 (da) | T-hjælpecelle-epitoper | |
NZ238833A (en) | Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom | |
JPS5533497A (en) | Silaasubstituted 1*44dihydropyridine derivative | |
UY24698A1 (es) | Promotor regulado por hierro y usos del mismo | |
BR9710849A (pt) | Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina. | |
AR041169A1 (es) | Polinucleotidos aislados que regulan la floracion de hierbas forrajeras y metodos de uso | |
ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20041027 |